OTCMKTS:TRSSF Terrascend Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Terrascend Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.54 -0.07 (-1.52 %) (As of 09/17/2020 12:00 AM ET) Add Compare Share Today's Range$4.49Now: $4.54▼$4.6550-Day Range$2.80MA: $4.14▼$4.8552-Week Range$1.19Now: $4.54▼$5.10Volume157,523 shsAverage Volume110,566 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestSocial Media TerrAscend Corp., a biopharmaceutical and wellness company, engages in the cultivation, development, and sale of medical cannabis in Canada. The company offers its cannabis products under the Knüba Naturals brand. It also provides education and support programs to physicians and patients through health care professionals. The company was incorporated in 2017 and is based in Mississauga, Canada.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingTerrascend has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.00, Terrascend has a forecasted upside of 32.2% from its current price of $4.54.Amount of Analyst CoverageTerrascend has only been the subject of 2 research reports in the past 90 days. Previous Next 4.2 Community Rank Outperform VotesTerrascend has received 40 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTerrascend has received 8 “underperform” votes. (Add your “underperform” vote.)Community SentimentTerrascend has received 83.33% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Terrascend and other stocks. Vote “Outperform” if you believe TRSSF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRSSF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTerrascend does not currently pay a dividend.Dividend GrowthTerrascend does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Terrascend insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 4.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.54 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TRSSF Previous Symbol CUSIPN/A CIKN/A Webwww.terrascend.com Phone855-837-7295Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $4.54 -0.07 (-1.52 %) (As of 09/17/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive TRSSF News and Ratings via Email Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter. Terrascend (OTCMKTS:TRSSF) Frequently Asked Questions How has Terrascend's stock been impacted by Coronavirus (COVID-19)? Terrascend's stock was trading at $1.8277 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TRSSF stock has increased by 148.4% and is now trading at $4.54. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Terrascend? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terrascend in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Terrascend. What price target have analysts set for TRSSF? 4 Wall Street analysts have issued 1 year price targets for Terrascend's shares. Their forecasts range from $5.50 to $6.50. On average, they anticipate Terrascend's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 32.2% from the stock's current price. View analysts' price targets for Terrascend. Are investors shorting Terrascend? Terrascend saw a increase in short interest in August. As of August 31st, there was short interest totaling 454,000 shares, an increase of 78.6% from the August 15th total of 254,200 shares. Based on an average daily volume of 309,400 shares, the short-interest ratio is presently 1.5 days. View Terrascend's Short Interest. Who are some of Terrascend's key competitors? Some companies that are related to Terrascend include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), Auscann Group (AC8), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cannpal Animal Therapeutics (CP1), Cansortium (CNTMF) and Charlotte's Web (CWBHF). View all competitors. Who are Terrascend's key executives? Terrascend's management team includes the following people: Dr. Michael Nashat, Founder, CEO, COO & Director (Age 35)Mr. Matthew J. Johnson, PresMr. Adam Kozak, Chief Financial OfficerMr. Alex Correia, VP of Corp. Affairs & CommunicationsMs. Dawn Vanek-Mithra, Director of Marketing What is Terrascend's stock symbol? Terrascend trades on the OTCMKTS under the ticker symbol "TRSSF." How do I buy shares of Terrascend? Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Terrascend's stock price today? One share of TRSSF stock can currently be purchased for approximately $4.54. What is Terrascend's official website? The official website for Terrascend is www.terrascend.com. How can I contact Terrascend? The company can be reached via phone at 855-837-7295. This page was last updated on 9/18/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
